Document:

Ex.
10.15

 

NOTE
PURCHASE AGREEMENT

 

This
Note Purchase Agreement (“Agreement”) is made and entered into on May 20, 2019 (“Effective Date”),
by and between Inception Mining, Inc., a Nevada corporation (“Company”),
and the investor whose name appears on the signature page hereto (“Investor”).

 

Recitals

 

A.
The parties desire that, upon the terms and subject to the conditions herein, Investor will purchase for $3 Million a Warrant
and a Promissory Note that is convertible into Common Stock of the Company; and

 

B.
The offer and sale provided for herein is being made pursuant to the exemptions from registration under Section 4(a)(2) of
the Act as a transaction by an issuer not involving any public offering, and as a private placement of restricted securities to
an accredited investor pursuant to Rule 506 of Regulation D.

 

Agreement

 

In
consideration of the foregoing, the receipt and adequacy of which are hereby acknowledged, Company and Investor agree as follows:

 

I.
Definitions. In addition to the terms defined elsewhere in this Agreement and the Transaction
Documents, capitalized terms that are not otherwise defined have the meanings set forth in the Glossary of Defined Terms attached
hereto as Exhibit 1.

 

II.
Purchase and Sale.

 

A.
Purchase Amount. Subject to the terms and conditions herein and the satisfaction of the
conditions to Closing set forth below, for an aggregate purchase price of $3,000,000.00 (“Purchase Amount”),
Investor hereby irrevocably agrees to purchase a Warrant and a Note with the aggregate Face Value of $4,250,000.00 including an
original issue discount (OID), all in accordance with the terms, provisions, and schedule set forth in this Agreement and in the
Transaction Documents.

 

B.
Deliveries. The following documents will be fully executed and delivered at the Closing:

 

	 	1.	This
    Agreement;
	 	 	 
	 	2.	Note,
    in the form attached hereto as Exhibit 2;
	 	 	 
	 	3.	Transfer
    Agent Instructions, in the form attached hereto as Exhibit 3;
	 	 	 
	 	4.	Legal
    Opinion, in the form attached hereto as Exhibit 4;

 

    	1

    	 

    

 

	 	5.	Officer’s
    Certificate, in the form attached hereto as Exhibit 5;
	 	 	 
	 	6.	Secretary’s
    Certificate, in the form attached hereto as Exhibit 6;
	 	 	 
	 	7.	Warrant,
    in the form attached hereto as Exhibit 7; and
	 	 	 
	 	8.	Public
    Deed, in the form attached hereto as Exhibit 8.

 

C.
Closing Conditions. The consummation of the transactions contemplated by this Agreement
(“Closing”) is subject to the satisfaction of each of the following conditions:

 

1.
All documents, instruments and other writings required to be delivered by Company to Investor pursuant to any provision of
this Agreement or in order to implement and effect the transactions contemplated herein have been fully executed and delivered,
including without limitation those enumerated in Section II.B above;

 

2.
The Common Stock is listed for and currently trading on the same or higher Trading Market and Company is in compliance with
all requirements to maintain listing on the Trading Market, the Company has received no notice
of any suspension or delisting with respect to the trading of the shares of Common Stock on such
Trading Market, and Company is not aware of any current facts or circumstances that, with the passage of time, would reasonably
be expected to cause such disqualification;

 

3.
The representations and warranties of Company and Investor set forth in this Agreement are true and correct in all material
respects as if made on such date (except for representations and warranties expressly made as of a specified date, which will
be true as of such date);

 

4.
No material breach or default has occurred
under any Transaction Document or any other agreement between Company and Investor;

 

5.
Company has the number of duly authorized shares of Common Stock reserved
for issuance as required pursuant to the terms of this Agreement;

 

6.
There is not then in effect any law, rule or regulation prohibiting or restricting the transactions contemplated in any Transaction
Document, or requiring any consent or approval which will not have been obtained, nor is there any completed, ongoing, pending,
threatened or, to Company’s knowledge, contemplated proceeding or investigation which may have the effect of prohibiting
or adversely affecting any of the transactions contemplated by this Agreement, including without limitation the sale, issuance,
listing, trading or resale of any Shares on the Trading Market; no statute, rule, regulation, executive order, decree, ruling
or injunction will have been enacted, entered, promulgated or adopted by any court or governmental authority of competent jurisdiction
that prohibits the transactions contemplated by this Agreement, and no actions, suits or proceedings will be completed, ongoing,
pending, threatened or, to Company’s knowledge, contemplated by any person other than Investor or any Affiliate of Investor,
that seek to enjoin or prohibit the transactions contemplated by this Agreement; and

 

    	2

    	 

    

 

7.
Except as set forth under the corresponding section of the Disclosure Schedules, any rights of first refusal, preemptive rights,
rights of participation, or any similar right to participate in the transactions contemplated by this Agreement, if any, have
been waived in writing.

 

D.
Closings. Immediately when all conditions set forth in Section II.C have
been fully satisfied, Company will issue and sell to Investor and Investor will purchase the Note by payment to Company of $3,000,000.00
in cash, by wire transfer of immediately available funds to an account designated by Company.

 

III.
Representations and Warranties.

 

A.
Representations Regarding Transaction. Except as set forth under the corresponding section
of the Disclosure Schedules, if any, Company hereby represents and warrants to, and as applicable covenants with, Investor as
of the Closing:

 

1.
Organization and Qualification. Company and each Subsidiary is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, as applicable,
with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted.
Neither Company nor any Subsidiary is in violation or default of any of the provisions of its respective certificate or articles
of incorporation, bylaws or other organizational or charter documents, except as would not reasonably be expected to result in
a Material Adverse Effect. Each of Company and each Subsidiary is duly qualified to conduct business and is in good standing as
a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by
it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, would
not reasonably be expected to result in a Material Adverse Effect and there is no completed, pending, threatened or, to the knowledge
of Company, contemplated proceeding in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail
such power and authority or qualification.

 

2.
Authorization; Enforcement.
Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by each
of the Transaction Documents and otherwise to carry out its obligations hereunder or thereunder. The execution and delivery of
each of the Transaction Documents by Company and the consummation by it of the transactions contemplated hereby or thereby have
been duly authorized by all necessary action on the part of Company and no further consent or action is required by Company. Each
of the Transaction Documents has been, or upon delivery will be, duly executed by Company and, when delivered in accordance with
the terms hereof, will constitute the valid and binding obligation of Company, enforceable against Company in accordance with
its terms, except (a) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors’ rights generally, (b) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (c) insofar as indemnification
and contribution provisions may be limited by applicable law.

 

    	3

    	 

    

 

3.
No Conflicts. The execution, delivery and performance of the Transaction Documents by Company, the issuance and sale
of the Note, Warrant and Shares and the consummation by Company of the other transactions contemplated thereby do not and will
not (a) conflict with or violate any provision of Company’s or any Subsidiary’s certificate or articles of incorporation,
bylaws or other organizational or charter documents, (b) conflict with, or constitute a default (or an event that with notice
or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets
of Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or without
notice, lapse of time or both) of, any material agreement, credit facility, debt or other instrument (evidencing Company or Subsidiary
debt or otherwise) or other understanding to which Company or any Subsidiary is a party or by which any property or asset of Company
or any Subsidiary is bound or affected, (c) conflict with or result in a violation of any material law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or governmental authority to which Company or a Subsidiary is subject
(including U.S. federal and state securities laws and regulations), or by which any property or asset of Company or a Subsidiary
is bound or affected, or (d) conflict with or violate the terms of any material agreement by which Company or any Subsidiary is
bound or to which any property or asset of Company or any Subsidiary is bound or affected; except in the case of each of clauses
(b), (c) and (d), such as would not reasonably be expected to result in a Material Adverse Effect.

 

4.
Litigation. There is no action, suit, inquiry, notice of violation,
proceeding or investigation completed, ongoing, pending, threatened or, to the knowledge of Company, contemplated against or affecting
Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative
agency or regulatory authority (federal, state, county, local or foreign) (collectively, an “Action”), which
would reasonably be expected to have a Material Adverse Effect or challenge the legality, validity or enforceability of any of
the Transaction Documents. The Commission has not issued any stop order or other order suspending the effectiveness of any registration
statement filed by Company or any Subsidiary under the Exchange Act or the Act.

 

5.
Filings, Consents and Approvals.
Neither Company nor any Subsidiary is required to obtain any
consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal,
state, local or other governmental authority or other Person in connection with the execution, delivery and performance by Company
of the Transaction Documents, other than required federal and state securities filings, and such filings and approvals as are
required to be made or obtained under the applicable Trading Market rules in connection with the transactions contemplated hereby,
each of which has been, or if not yet required to be filed will be, timely filed.

 

6.
Issuance of Shares. The Shares are duly authorized and, when issued upon the conversion of the Note or exercise of
the Warrant in accordance with their respective terms, will be duly and validly issued, fully paid and nonassessable, free and
clear of all Liens except those created by the Investor.

 

    	4

    	 

    

 

7.
Disclosure; Non-Public Information.
Company will timely file a current report on Form 8-K (“Current
Report”) describing the material terms and conditions of this Agreement, a copy of which has been provided to Investor
prior to the Effective Date. There is no adverse material information regarding Company that has not been disclosed to Investor
prior to the Effective Date. All information that Company has provided to Investor
that constitutes or might constitute material, non-public information will be included in the Current Report. Notwithstanding
any other provision, except with respect to information that will be, and only to the extent that it actually is, timely publicly
disclosed by Company pursuant to the foregoing sentence, neither Company nor any other Person acting on its behalf has provided
Investor or its representatives, agents or attorneys with any information that constitutes or might constitute material, non-public
information, including without limitation this Agreement and the Exhibits and Disclosure Schedules hereto. No information contained
in the Disclosure Schedules constitutes material non-public information. Company understands and confirms that Investor will rely
on the foregoing representations and covenants in effecting transactions in securities of Company.

 

8.
No Integrated Offering. Neither Company, nor any of its Affiliates, nor any Person acting on its or their behalf has,
directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances
that would cause this offering to be integrated with prior offerings by Company that cause a violation of the Act or any applicable
stockholder approval provisions, including, without limitation, under the rules and regulations of the Trading Market.

 

9.
Financial Condition. The Public Reports
set forth as of the dates thereof all outstanding secured and unsecured Indebtedness of Company or any Subsidiary, or for which
Company or any Subsidiary has commitments, and any material default with respect to any Indebtedness. Company does not intend
to incur debts beyond its ability to pay such debts as they mature, taking into account the timing and amounts of cash to be payable
on or in respect of its debt, and represents that it will not do so.

 

10.
Section 5 Compliance. All information provided to Investor regarding Company, its business and the transactions contemplated
hereby, including without limitation the Disclosure Schedules and the representations and warranties in this Agreement, and the
other statements made by Company in the Transaction Documents, do not contain any material untrue statement or omit to state a
material fact necessary to make any of them, in light of the circumstances in which it was made, not misleading. Company is not
aware of any facts or circumstances that would cause the transactions contemplated by the Transaction Documents, when consummated,
to violate Section 5 of the Act or other federal or state securities laws or regulations.

 

11.
Investment Company. Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Note,
will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940,
as amended. Company will conduct its business in a manner so that it will not become subject to the Investment Company Act.

 

12.
Acknowledgments Regarding Investor. Company’s decision to enter into this Agreement has been based solely on
the independent evaluation by Company and its representatives, and Company acknowledges and agrees that:

 

    	5

    	 

    

 

a.
Investor is not, has never been, and as a result of the transactions contemplated by the Transaction Documents will not become
an officer, director, insider or control person of Company, or to Company’s knowledge 10% or greater shareholder or otherwise
an affiliate of Company as defined under Rule 12b-2 of the Exchange Act;

 

b.
Investor and its representatives have not made and do not make any representations, warranties or agreements with respect
to the Note, the Warrant, the Shares, this Agreement, or the transactions contemplated hereby other than those specifically set
forth in Section III.C below; Company has not relied upon, and expressly disclaims reliance upon, any and all written or
oral statements or representations made by any persons prior to this Agreement;

 

c.
The conversion of Note and resale of Conversion Shares will result in dilution, which may be substantial; the number of Conversion
Shares will increase in certain circumstances; and Company’s obligation to issue and deliver Conversion Shares in accordance
with this Agreement and the Note is absolute and unconditional regardless of the dilutive effect that such issuances may have;
and

 

d.
Investor is acting solely in the capacity of arm’s length purchaser with respect to this Agreement and the transactions
contemplated hereby; neither Investor nor any of its Affiliates, agents or representatives has or is acting as a legal, financial,
investment, accounting, tax or other advisor to Company, or fiduciary of Company, or in any similar capacity; neither Investor
nor any of its Affiliates, agents or representatives has provided any legal, financial, investment, accounting, tax or other advice
to Company; any statement made in connection with this Agreement or the transactions contemplated hereby is not advice or a recommendation,
and is merely incidental to Investor’s purchase of the Note.

 

13.
No Bad Actor Disqualification. Neither Company, any predecessor of Company, any affiliate of Company, any director,
executive officer, other officer of Company participating in the offering, or any beneficial owner of 20% or more of Company’s
outstanding voting equity securities is subject to any bad actor disqualification as provided in Rule 506(d) of Regulation D,
and Company is not aware of any current facts or circumstances that, with the passage of time, would reasonably be expected to
cause such disqualification.

 

14.
Not a Shell. Company is not a shell company as defined in Rule 12b-2 of the Exchange Act.

 

B.
Representations Regarding Company. Except as set forth in any Public Reports and attached
exhibits, or under the corresponding section of the Disclosure Schedules, if any, Company hereby represents and warrants to, and
as applicable covenants with, Investor as of the Closing:

 

    	6

    	 

    

 

1.
Capitalization. The capitalization of the Company as of the Effective Date is as described in the Public Reports or
Disclosure Schedules. No Person has any right of first refusal, preemptive right, right of participation, or any similar right
to participate in the transactions contemplated by the Transaction Documents which has not been waived or satisfied. Except as
a result of the purchase and sale of the Note, there are no outstanding options, warrants, script rights to subscribe to, calls
or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exchangeable
for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock, or contracts, commitments, understandings
or arrangements by which Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or securities
convertible into or exercisable for shares of Common Stock. The issuance and sale of the Note, Warrant and Shares will not obligate
Company to issue shares of Common Stock or other securities to any Person, other than Investor, and will not result in a right
of any holder of Company securities to adjust the exercise, conversion, exchange, or reset price under such securities. All of
the outstanding shares of capital stock of Company are validly issued, fully paid and nonassessable, have been issued in material
compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive
rights or similar rights to subscribe for or purchase securities. No further
approval or authorization of any stockholder, the Board of Directors of Company or others is required for the issuance and sale
of the Note, Warrant and Shares. There are no existing or contemplated subscription or investment agreements, stockholder agreements,
voting agreements or other similar agreements with respect to Company’s capital stock to which Company is a party or, to
the knowledge of Company, between or among any of Company’s stockholders.

 

2.
Subsidiaries. All of the direct and indirect subsidiaries of Company are set forth in the Public Reports or the corresponding
section of the Disclosure Schedules. Company owns, directly or indirectly, all
of the capital stock or other equity interests of each Subsidiary, and all of such directly or indirectly owned capital stock
or other equity interests are owned free and clear of any Liens. All the issued
and outstanding shares of capital stock of each Subsidiary are duly authorized, validly issued, fully paid, nonassessable and
free of preemptive and similar rights to subscribe for or purchase securities.

 

3.
Public Reports; Financial Statements. Company has filed all required
Public Reports for the one year preceding the Effective Date. As of their respective
dates or as subsequently amended, the Public Reports complied in all material respects with the requirements of the Act and the
Exchange Act and the rules and regulations of the Commission promulgated thereunder, as applicable, and none of the Public Reports,
when filed and, as applicable, amended, contained any untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which
they were made, not misleading. The financial statements of Company included in the Public Reports, as amended, comply in all
material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto
as in effect at the time of filing. Such financial statements have been prepared in accordance with GAAP, except as may be otherwise
specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all
footnotes required by GAAP, and fairly present in all material respects the financial position of Company and its consolidated
subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject,
in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.

 

    	7

    	 

    

 

4.
Material Changes. Since the end of the most recent year for which an Annual Report on Form 10-K has been filed with
the Commission, (a) there has been no event, occurrence or development that has had, or that would reasonably be expected to result
in, a Material Adverse Effect, (b) Company has not incurred any liabilities (contingent or otherwise) other than (i) trade payables
and accrued expenses incurred in the ordinary course of business consistent with past practice, and (ii) liabilities not required
to be reflected in Company’s financial statements pursuant to GAAP or required to be disclosed in filings made with the
Commission, (c) Company has not altered its method of accounting, (d) Company has not declared or made any dividend or distribution
of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of
its capital stock, and (e) Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing Company equity incentive plans. Company does not have pending before the Commission any request for confidential treatment
of information.

 

5.
Litigation. There is no Action completed, ongoing, pending, threatened
or, to the knowledge of Company, contemplated, that would reasonably be expected to result in a Material Adverse Effect. Neither
Company nor any Subsidiary, nor any current director or officer thereof, nor to the knowledge of Company any former director or
officer of Company, and greater than 5% shareholder of Company, or any director or officer thereof, is or has been the subject
of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary
duty. There has not been, is not ongoing, pending or threatened, and to the knowledge of Company is not contemplated, any investigation
by the Commission or any law enforcement agency involving Company or any current director or officer of Company, or to the knowledge
of Company any former director or officer of Company, and greater than 5% shareholder of Company, or any director or officer thereof.

 

6.
No Bankruptcy. The Company has not filed and, to the Company’s knowledge, no other Person has filed or commenced,
any petition or application, or any judicial or administrative proceeding commenced which has not been discharged, with respect
to the Company or any Subsidiary or with respect to any of the properties or assets of Company or any Subsidiary under any applicable
law relating to bankruptcy, insolvency, reorganization, fraudulent transfer, compromise, arrangement of debt, creditors’
rights and no general assignment has been made by the Company or any Subsidiary for the benefit of creditors.

 

7.
Labor Relations. No material labor dispute exists or, to the knowledge
of Company, is imminent with respect to any of the employees of Company, which would reasonably be expected to result in a Material
Adverse Effect.

 

8.
Compliance. Neither Company nor any Subsidiary (a) is in material
default under or in material violation of (and no event has occurred that has not been waived that, with notice or lapse of time
or both, would result in a default by Company or any Subsidiary under), nor has Company or any Subsidiary received notice of a
claim that it is in material default under or that it is in material violation of, any indenture, loan or credit agreement or
any other similar agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or
not such default or violation has been waived), (b) is in violation of any order of any court, arbitrator or governmental body,
or (c) is or has been in violation of any statute, rule or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws applicable to its business, except in each case as would not reasonably be expected
to have a Material Adverse Effect.

 

    	8

    	 

    

 

9.
Regulatory Permits. Company and each Subsidiary possess all certificates, authorizations and permits issued by the
appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described
in the Public Reports, except where the failure to possess such permits would not, individually or in the aggregate, reasonably
be expected to result in a Material Adverse Effect (“Material Permits”), and neither Company nor any Subsidiary
has received any notice of proceedings relating to the revocation or modification of any Material Permit.

 

10.
Title to Assets. Company and each Subsidiary have good and marketable title
in fee simple to all real property owned by them that is material to the business of Company and each Subsidiary and good
and marketable title in all personal property owned by them that is material to the business of Company and each Subsidiary, in
each case free and clear of all Liens, except for Liens that do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by Company and each Subsidiary and Liens for the payment
of federal, state or other taxes, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities
held under lease by Company and each Subsidiary are held by them under leases which, to the Company’s knowledge, are valid,
subsisting and enforceable leases and as to which Company and each Subsidiary are in compliance, except where such noncompliance
could not reasonably be expected to have a Material Adverse Effect.

 

11.
Patents and Trademarks. Company and each Subsidiary have, or have
rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, copyrights, licenses
and other similar rights that are necessary or material for use in connection with their respective businesses as described in
the Public Reports and which the failure to so have would have a Material Adverse Effect (collectively, “Intellectual
Property Rights”). Neither Company nor any Subsidiary has received a written notice that the Intellectual Property Rights
used by Company or any Subsidiary violates or infringes
upon the rights of any Person. To the knowledge of Company, all such Intellectual Property Rights are enforceable and there
is no existing infringement by another Person of any of the Intellectual Property Rights of Company or each Subsidiary.

 

12.
Transactions with Affiliates and Employees. None of the officers or directors of Company and, to the knowledge of Company,
none of the employees of Company is presently a party to any transaction with Company or any Subsidiary (other than for services
as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of
services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any
officer, director or such employee or, to the knowledge of Company, any entity in which any officer, director, or any such employee
has a substantial interest or is an officer, director, trustee or partner, in each case in excess of $120,000 other than (i) for
payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of Company and
(iii) for other employee benefits, including stock option agreements under any equity incentive plan of Company.

 

    	9

    	 

    

 

13.
Certain Fees. No brokerage or finder’s fees or commissions are or will be payable to any broker, financial advisor
or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated
by this Agreement as a result of any action by the Company or any Person acting on its behalf. Notwithstanding any other provision,
Investor will have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons
for fees of a type contemplated in this section that may be due in connection with the transactions contemplated by this Agreement
or the other Transaction Documents.

 

14.
Registration Rights. No Person has any right to cause Company to effect the registration under the Act of any securities
of Company.

 

15.
Listing and Maintenance Requirements.
The Common Stock is registered pursuant to Section 12 of the
Exchange Act, and Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating
the registration of the Common Stock under the Exchange Act nor has Company received any notification that the Commission is contemplating
terminating such registration. Company has not, in the 12 months preceding the Effective Date, received notice from any Trading
Market on which the Common Stock is or has been listed or quoted to the effect that Company is not in compliance with the listing
or maintenance requirements of such Trading Market. Company is, and has no reason to
believe that it will not in the foreseeable future continue to be, in compliance with all listing and maintenance requirements
of the Trading Market on which the Common Stock is currently quoted.

 

16.
Foreign Corrupt Practices. Neither Company, nor to the knowledge of Company, any agent or other person acting on behalf
of Company, has (a) directly or indirectly, used any corrupt funds for unlawful contributions, gifts, entertainment or other unlawful
expenses related to foreign or domestic political activity, (b) made any unlawful payment to foreign or domestic government officials
or employees or to any foreign or domestic political parties or campaigns from corporate funds, (c) failed to disclose fully any
contribution made by Company, or made by any person acting on its behalf of which Company is aware, which is in violation of law,
or (d) violated in any material respect any provision of the Foreign Corrupt Practices Act of 1977, as amended.

 

17.
Auditor. Company’s auditor is set forth in the Public Reports and
such auditor is an independent registered public accounting firm registered with the PCAOB.

 

18.
No Disagreements with Accountants or Lawyers. There are no material disagreements presently existing, or reasonably
anticipated by Company to arise, between Company and the accountants or lawyers formerly or presently employed by Company.

 

19.
Powers of Attorney. There are no outstanding powers of attorney executed on behalf of the Company or any Subsidiary.

 

20.
Computer and Technology Security. Company has taken reasonable steps to safeguard the information technology systems
utilized in the operation of the business of Company, including the implementation of procedures designed to minimize the risk
that such information technology systems have any disabling codes or instructions, timer, copy protection device, clock, counter
or other limiting design or routing and any back door, virus, malicious code or other software routines or hardware components
that in each case permit unauthorized access or the unauthorized disablement or unauthorized erasure of data or other software
by a third party, and, to Company’s knowledge, to date there have been no successful unauthorized intrusions or breaches
of the security of its information technology systems.

 

    	10

    	 

    

 

21.
Data Privacy. Company has: (a) complied with, and is presently in compliance in all material respects with, all applicable
laws in connection with data privacy, information security, data security and/or personal information; (b) complied in all material
respects with, and is presently in material compliance with, its policies and procedures applicable to data privacy, information
security, data security, and personal information; (c) not experienced any material incident in which personal information or
other sensitive data was or may have been stolen or improperly accessed; and Company is not aware of any facts suggesting the
likelihood of the foregoing, including without limitation, any breach of security or receipt of any notices or complaints from
any Person regarding personal information or other data.

 

C.
Representations and Warranties of Investor. Investor hereby represents and warrants to
Company as of the Closing as follows:

 

1.
Organization; Authority.
Investor is an entity validly existing and in good standing under the laws of the jurisdiction of its organization with full right,
company power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise
to carry out its obligations thereunder. The execution, delivery and performance by Investor of the transactions contemplated
by this Agreement have been duly authorized by all necessary company or similar action on the part of Investor. Each Transaction
Document to which it is a party has been, or will be, duly executed by Investor, and when delivered by Investor in accordance
with the terms hereof, will constitute the valid and legally binding obligation of Investor, enforceable against it in accordance
with its terms, except (a) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors’ rights generally, (b) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies, and (c) insofar as indemnification
and contribution provisions may be limited by applicable law.

 

2.
Investor Status. At the time Investor was offered the Note, it was, and at the Effective Date it is: (a) an accredited
investor as defined in Rule 501(a) under the Act; and (b) not a registered broker-dealer, member of FINRA, or an affiliate thereof.

 

3.
Experience of Investor. Investor, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Note, and has so evaluated the merits and risks of such investment. Investor is able to bear the economic risk of an investment
in the Note and, at the present time, is able to afford a complete loss of such investment.

 

4.
Ownership. Investor is acquiring the Note as principal for its own account.

 

    	11

    	 

    

 

5.
No Short Sales. Neither Investor nor any Affiliate holds any short position in, nor has engaged in any Short Sales
of the Common Stock, or engaged in any hedging transactions with regard to the Conversion Shares prior to the Effective Date.

 

IV.
Other Provisions.

 

A.
Investor Due Diligence. Investor will have the right and opportunity to conduct customary
due diligence with respect to any Registration Statement or Prospectus in which the name of Investor or any Affiliate of Investor
appears, and will review and respond promptly to Company requests.

 

B.
Furnishing of Information. As long as the Note is outstanding in any amount: (1) Company
will timely file all reports required to be filed by Company after the Effective Date pursuant to the Exchange Act, (2) Company
will prepare and make publicly available such information as is required for Investor to sell its Conversion Shares under Rule
144, and (3) Company will take such further action as Investor may reasonably request, all to the extent required from time to
time to enable Investor to sell its Conversion Shares without registration under the Act within the limitation of the exemptions
provided by Rule 144.

 

C.
Integration. Company will not sell, offer for sale or solicit offers to buy or otherwise
negotiate in respect of any security, as defined in Section 2 of the Act, that would be integrated with the offer or sale of the
Note, Warrant or Shares to Investor for purposes of the rules and regulations of any Trading Market such that it would require
stockholder approval prior to the closing of such other transaction unless stockholder approval is obtained before the closing
of such subsequent transaction.

 

D.
Disclosure and Publicity. Company will provide to Investor, for review and approval prior
to filing or issuing, that portion of any current, periodic or public report, registration statement, press release, public statement
or communication relating to or referencing Investor, any Transaction Documents or the transactions contemplated thereby, any
such approval not to be unreasonably withheld.

 

E.
Shareholders Rights Plan. No claim will be made or enforced by Company or, to the knowledge
of Company, any other Person that Investor is an “Acquiring Person” under any shareholders rights plan or similar
plan or arrangement in effect or hereafter adopted by Company, or that Investor could be deemed to trigger the provisions of any
such plan or arrangement, in either such case, by virtue of receiving Shares under the Transaction Documents or under any other
agreement between Company and Investor. Company will conduct its business in a manner so that it will not become subject to the
Investment Company Act of 1940, as amended.

 

F.
No Non-Public Information. Company covenants and agrees that neither it nor any other
Person acting on its behalf will, provide Investor or its agents or counsel with any information that Company believes or reasonably
should believe will constitute material non-public information after Closing. On and after Closing, neither Investor nor any Affiliate
of Investor will have any duty of trust or confidence that is owed directly, indirectly, or derivatively, to Company or the stockholders
of Company, or to any other Person who is the source of material non-public information regarding Company. Company understands
and confirms that Investor will be relying on the foregoing in effecting transactions in securities of Company, including without
limitation resales of the Shares.

 

    	12

    	 

    

 

G.
Indemnification of Investor.

 

1.
Obligation to Indemnify. Subject
to the provisions of this Section IV.G, Company will indemnify and hold Investor, its
Affiliates, managers and advisors, and each of their officers, directors, shareholders, partners, employees, representatives,
agents and attorneys, and any person who controls Investor within the meaning of Section 15 of the Act or Section 20 of the Exchange
Act (collectively, “Investor Parties” and each a “Investor Party”),
harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, reasonable costs and expenses, including
all judgments, amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation (collectively,
“Losses”) that any Investor Party may suffer or incur as a result of or relating
to (a) any breach of any of the representations, warranties, covenants or agreements made by Company in this Agreement or in the
other Transaction Documents, (b) any untrue statement or alleged untrue statement of
a material fact contained in the Registration Statement, Prospectus, Prospectus Supplement, or any
information incorporated by reference therein, or arising out of or based upon any omission or alleged omission to state
a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading, or (c) any action by a creditor or stockholder of Company who is not an Affiliate of an Investor Party, challenging
the transactions contemplated by the Transaction Documents; provided, however, that Company will not be obligated to indemnify
any Investor Party for any Losses finally adjudicated to be caused solely by (i) a false statement of material fact contained
within written information provided by such Investor Party expressly for the purpose of including it in the applicable Registration
Statement, Prospectus, Prospectus Supplement, or (ii) such Investor Party’s unexcused material breach of an express provision
of this Agreement or another Transaction Document or willful misconduct or fraud.

 

2.
Procedure for Indemnification. If any action will be brought against an Investor Party in respect of which indemnity
may be sought pursuant to this Agreement, such Investor Party will promptly notify Company in writing, and Company will have the
right to assume the defense thereof with counsel of its own choosing. Investor Parties will have the right to employ separate
counsel in any such action and participate in the defense thereof, but the reasonable fees and expenses of such counsel will be
at the expense of Investor Parties except to the extent that (a) the employment thereof has been specifically authorized by Company
in writing, (b) Company has failed after a reasonable period of time to assume such defense and to employ counsel or (c) in such
action there is, in the reasonable opinion of such separate counsel, a material conflict with
respect to the dispute in question on any material issue between the position of Company and the position of Investor
Parties such that it would be inappropriate for one counsel to represent Company and Investor Parties. Company will not
be liable to Investor Parties under this Agreement (i) for any settlement by an Investor Party effected without Company’s
prior written consent, which will not be unreasonably withheld or delayed; or (ii) to the extent, but only to the extent that
a loss, claim, damage or liability is either attributable to Investor’s
breach of any of the representations, warranties, covenants or agreements made by Investor in this Agreement or in the other Transaction
Documents or willful misconduct or fraud. In no event will the Company be liable for the reasonable fees and expenses for more
than one separate firm of attorneys (plus local counsel as applicable) to represent all Investor Parties.

 

    	13

    	 

    

 

3.
Other than the liability of Investor to Company for uncured material breach of the express provisions
of this Agreement or willful misconduct or fraud, no Investor Party will have any liability
to Company or any Person asserting claims on behalf of or in right of Company as a result of acquiring the Note, Warrant
or Shares under this Agreement.

 

H.
Reservation of Shares. Company has reserved from its duly authorized Common Stock for
issuance pursuant to the Transaction Documents authorized shares of Common Stock in the amount required by the Transaction Documents
and will at all times maintain such reserve (the “Reserved Amount”). If Company
shall issue any securities or make any change to its capital structure which would change the number of shares of Common Stock
into which the Note or Warrant shall be convertible or exercisable at the then current Conversion Price or Exercise Price, Company
will at the same time make proper provision so that thereafter there shall be a sufficient number of shares of Common Stock authorized
and reserved, free from preemptive rights, for conversion of the outstanding Note and exercise of the outstanding Warrant. Company
(i) acknowledges that it has irrevocably instructed its transfer agent to issue certificates for the Common Stock issuable upon
conversion of the Note and exercise of the Warrant, and agrees that its issuance of the Note and Warrant will constitute full
authority to its officers and agents who are charged with the duty of executing stock certificates to execute and issue the necessary
certificates for shares of Common Stock in accordance with the terms and conditions of the Note and Warrant.

 

I.
Activity Restrictions. For so long as Investor or any of its Affiliates holds any Conversion
Shares, neither Investor nor any Affiliate will: (1) vote any shares of Common Stock owned or controlled by it, sign or solicit
any proxies, attend or be present at a shareholder meeting for purposes of determining a quorum, or seek to advise or influence
any Person with respect to any voting securities of Company, except in accordance with the recommendation of Company’s board
of directors; (2) engage or participate in any actions, plans or proposals which relate to or would result in (a) acquiring additional
securities of Company, alone or together with any other Person, which would result in beneficially owning or controlling more
than 9.99% of the total outstanding Common Stock or other voting securities of Company, (b) an extraordinary corporate transaction,
such as a merger, reorganization or liquidation, involving Company or any of its Subsidiaries, (c) a sale or transfer of a material
amount of assets of Company or any of its Subsidiaries, (d) any change in the present board of directors or management of Company,
including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board, (e)
any material change in the present capitalization or dividend policy of Company, (f) any other material change in Company’s
business or corporate structure, including but not limited to, if Company is a registered closed-end investment company, any plans
or proposals to make any changes in its investment policy for which a vote is required by Section 13 of the Investment Company
Act of 1940, (g) changes in Company’s charter, bylaws or instruments corresponding thereto or other actions which may impede
the acquisition of control of Company by any Person, (h) a class of securities of Company being delisted from a national securities
exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association,
(i) a class of equity securities of Company becoming eligible for termination of registration pursuant to Section 12(g)(4) of
the Act, or (j) any action, intention, plan or arrangement similar to any of those enumerated above; or (3) request Company or
its directors, officers, employees, agents or representatives to amend or waive any provision of this section.

 

    	14

    	 

    

 

J.
No Shorting. For so long as the Note is outstanding in any amount, neither Investor nor
any of its Affiliates will engage in or effect, directly or indirectly, any Short Sale of Common Stock. For the avoidance of doubt,
Investor selling Shares after Investor has delivered a Delivery Notice to Company is not a Short Sale. There will be no restriction
or limitation of any kind on Investor’s right or ability to sell or transfer any or all of the Shares at any time, in its
sole and absolute discretion. Investor may not sell, transfer or assign the Note, the Warrant or any of its rights under this
Agreement.

 

K.
Stock Splits. If Company at any time on or after the Effective Date subdivides (by any
stock split, stock dividend, recapitalization or otherwise) or combines (by combination, reverse stock split or otherwise) one
or more classes of its outstanding shares of Common Stock into a greater or lesser number of shares, the share numbers, prices
and other amounts set forth in this Agreement, as in effect immediately prior to such subdivision or combination, will be proportionately
reduced or increased, as applicable, effective at the close of business on the date the subdivision or combination becomes effective.

 

L.
Subsequent Financings.

 

1.
As long as the Note is outstanding in any amount, Company will not enter into any agreement
that in any way restricts its ability to enter into any agreement, amendment or waiver with Investor, including without limitation
any agreement to offer, sell or issue to Investor any preferred stock, common stock or other securities of Company.

 

2.
Until six months after Closing, Company will not enter into any financing that uses a shelf
registration, contains registration rights or otherwise provides for the issuance of free trading stock, other than: (a) with
Investor, (b) in connection with a strategic transaction, or (c) the sale of restricted Common Stock at a fixed price. For the
avoidance of doubt, Company may enter into any unregistered financing of nonconvertible debt or restricted stock with no registration
rights.

 

3.
As long as any part of the Note is outstanding, Company will not agree or enter into any equity
or convertible financing pursuant to which shares of Common Stock or Common Stock equivalents may effectively be issued at a variable
price or where the price or number of shares are subject to any type of variability or reset feature. Provided, however, that
Company may enter into any transaction: (a) with Investor, (b) for unregistered, non-convertible debt, (c) for restricted stock
with no registration rights, (d) for Common Stock at a fixed price at no more than a 5% discount to the most recent closing price
of the Common Stock on the Trading Market, (e) reasonably equivalent value given as consideration for a strategic acquisition,
or (f) that includes an immediate, unconditional offer to Investor to purchase the Note by wire transfer of immediately available
funds in the amount of 140% of the then outstanding Liquidation Value.

 

    	15

    	 

    

 

4.
So long as any part of the Note is outstanding, upon any issuance by Company or any of its subsidiaries
of any security with any term more favorable to the holder of such security or with a term in favor of the holder of such security
that was not similarly provided to Investor, then Company will notify Investor of such additional or more favorable term and such
term, at Investor’s option, shall become a part of the transaction documents with Investor. The types of terms contained
in another security that may be more favorable to the holder of such security include, but are not limited to, terms addressing
conversion discounts, prepayment rate, conversion look back periods, interest rates, original issue discounts, stock sale price,
private placement price per share, and warrant coverage.

 

M.
Right of First Refusal. If at any time while the Note is outstanding in any amount, Company
has a bona fide offer of capital or financing from any person, that Company intends to act upon, then Company must first offer
such opportunity to Investor to provide such capital or financing to Company on the same terms as each respective person’s
terms. Except as otherwise provided in any Transaction Documents, should Investor be unwilling or unable to provide such capital
or financing to Company within 5 Trading Days from Investor’s receipt of written notice of the offer from Company, then
Company may obtain such capital or financing from that respective person upon the exact same terms and conditions offered by Company
to Investor, which transaction must be completed within 30 days after the date of the notice. If Company does not receive the
capital or financing from the respective person within 30 days after the date of the respective notice, then Company must again
offer the capital or financing opportunity to Investor as described above, and the process detailed above shall be repeated.

 

V.
Registration Statement.

 

A.
Filing.

 

1.
Company will at its sole cost and expense prepare and file with the Commission as soon as reasonably possible after the Effective
Date, and in any event within 30 days, a Registration Statement (“Registration Statement”) on Form S-3 or,
if Form S-3 is unavailable, Form S-1, registering the delayed and continuous resale of all Shares pursuant to Rule 415 under the
Act, and will use reasonable best efforts to cause such Registration Statement to be declared effective under the Act as promptly
as practicable, and in any event within 75 days of Closing, and to remain continuously effective until all Shares may be resold
by Investor pursuant to Rule 144 without volume restrictions, manner-of-sale restrictions, or Company being in compliance with
any current public information requirement (the “Registration Period”).

 

2.
If at any time after the initial registration Statement is filed on Form S-3 or Form S-1, the Registration Statement does
not remain effective, Company shall use reasonable best efforts to amend the Registration Statement to continue effectiveness
uninterrupted.

 

B.
Procedures. In connection with the Registration Statement, Company will, as soon as reasonably practicable:

 

1.
Prepare and file with the Commission such pre-effective and post-effective amendments and supplements to the Registration
Statement and the Prospectus used in connection with the Registration Statement, and file such reports under the Exchange Act,
as may be necessary to cause the Registration Statement to become effective, to keep the Registration Statement continuously effective
during the Registration Period and not misleading in any material respect, and as may otherwise be required or applicable under,
and to comply with the provisions of, the Act with respect to the disposition of all Shares covered by the Registration Statement
during the Registration Period.

 

    	16

    	 

    

 

2.
Furnish to Investor such number of copies of the Prospectus, and each amendment or supplement thereto, in conformity with
the requirements of the Act, and such other documents as Investor may reasonably request in order to facilitate the disposition
of Shares owned by it.

 

3.
Notify Investor: (a) when a Prospectus or any Prospectus supplement or post-effective amendment is proposed to be filed and,
with respect to any post-effective amendment, when the same has become effective, except for any filing to be made solely to incorporate
by reference a Current Report on Form 8-K, Quarterly Report on Form 10-Q or Annual Report on Form 10-K to be filed with the Commission;
(b) of any request by the Commission or any other federal or state governmental authority for amendments or supplements to a Registration
Statement or a Prospectus or for additional information; (c) of the issuance by the Commission of any stop order suspending the
effectiveness of a Registration Statement or the initiation of any proceedings for that purpose; (d) of the receipt by the Company
of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Shares for
sale in any jurisdiction, or the initiation or threatening of any proceeding for such purpose, and (e) of the occurrence of any
event or circumstance that makes any statement made in the Registration Statement or Prospectus or any document incorporated or
deemed to be incorporated therein by reference untrue in any material respect or that requires the making of any changes in the
Registration Statement, Prospectus or documents so that, in the case of a Registration Statement or the Prospectus, as the case
may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; provided,
however, in no event shall any such notice contain any information which would constitute material, non-public information regarding
the Company.

 

4.
Use reasonable best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of, any order suspending the effectiveness
of the Registration Statement, or the lifting of any suspension of the qualification, or exemption from qualification, of any
of the Shares for sale in any jurisdiction, at the earliest practicable moment.

 

5.
Incorporate in a Prospectus supplement or post-effective amendment such information as Investor requests be included therein
regarding Investor or the plan of distribution of the Shares; and make all required filings of the Prospectus supplement or such
post-effective amendment as soon as practicable after the Company has received notification of such matters to be incorporated
in such Prospectus supplement or post-effective amendment; provided, however, that the Company shall not be required to take any
action pursuant to this paragraph that would violate applicable law.

 

    	17

    	 

    

 

6.
Whenever necessary, prepare and deliver to Investor any required supplement or amendment, including a post-effective amendment,
to the Registration Statement or a supplement to the Prospectus or any document incorporated or deemed to be incorporated therein
by reference, and file any other required document, including such reports as may be required to be filed under the Exchange Act,
so that, as thereafter delivered, the Prospectus will not contain an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they
were made, not misleading.

 

7.
Use reasonable best efforts to cause all Shares to be listed on the Trading Market or such other securities exchange or automated
quotation system, if any, as is then the principal securities exchange or automated quotation system on which the Common Stock
is then listed.

 

8.
Fully cooperate with the Transfer Agent, Investor and its brokers to facilitate the timely clearing and delivery of Shares
to be sold pursuant to the Registration Statement free of any restrictive legends and in such denominations and registered in
such names as Investor may reasonably request, including timely completion and delivery of all forms, documents and instruments
requested by the Transfer Agent or any broker.

 

VI.
General Provisions.

 

A.
Notice. Unless a different time of day or method of delivery is specifically provided
in the Transaction Documents, any and all notices or other communications or deliveries required or permitted to be provided hereunder
will be in writing and will be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or
communication is delivered via facsimile or electronic mail prior to 5:00 p.m. New York time on a Trading Day and an electronic
confirmation of delivery is received by the sender, (b) the next Trading Day after the date of transmission, if such notice or
communication is delivered later than 5:00 p.m. New York time or on a day that is not a Trading Day, (c) the next Trading Day
following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (d) upon actual receipt by
the party to whom such notice is required to be given. The addresses for such notices and communications are such other address
as may be designated in writing, in the same manner, by such Person.

 

B.
Amendments; Waivers. No provision of this Agreement may be waived or amended except in
a written instrument signed, in the case of an amendment, by Company and Investor or, in the case of a waiver, by the party against
whom enforcement of any such waiver is sought. No waiver of any default with respect to any provision, condition or requirement
of this Agreement will be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of
any other provision, condition or requirement hereof, nor will any delay or omission of either party to exercise any right hereunder
in any manner impair the exercise of any such right.

 

C.
No Third-Party Beneficiaries. Except as otherwise set forth in Section IV.G,
this Agreement and the Transaction Documents will inure solely to the benefit of the parties hereto, and is not for the benefit
of, nor may any provision hereof be enforced by, any other Person. Other than the Investor Parties described in Section
IV.G, a Person who is not a party to this Agreement shall not have any rights under the Contracts
(Rights of Third Parties) Law, 2014 of the Cayman Islands to enforce any term of this Agreement or any Transaction Document.

 

    	18

    	 

    

 

D.
Fees and Expenses. Company has paid a flat rate documentation fee of $10,000 to Investor
in connection with drafting this Agreement and the other Transaction Documents. Except as otherwise provided in this Agreement,
each party will pay the fees and expenses of its own advisers, counsel, accountants and other experts, if any, and all other expenses
incurred by such party incident to the negotiation, preparation, execution, delivery and performance of the Transaction Documents.
Company acknowledges and agrees that Investor’s counsel solely represents Investor, and does not represent Company or its
interests in connection with the Transaction Documents or the transactions contemplated thereby. Company will pay all stamp and
other taxes and duties, if any, levied in connection with the sale or issuance of the Shares to Investor.

 

E.
Severability. If any provision of this Agreement is held to be invalid or unenforceable
in any respect, the validity and enforceability of the remaining terms and provisions of this Agreement will not in any way be
affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable
substitute therefor, and upon so agreeing, will incorporate such substitute provision in this Agreement.

 

F.
Replacement of Certificates. If any
certificate or instrument evidencing any Shares is mutilated, lost, stolen or destroyed, Company will issue or cause to be issued
in exchange and substitution for and upon cancellation thereof, or in lieu of and substitution therefor, a new certificate or
instrument, but only upon receipt of evidence reasonably satisfactory to Company of such loss, theft or destruction and customary
and reasonable indemnity, if requested. The applicants for a new certificate or instrument under such circumstances will also
pay any reasonable third-party costs associated with the issuance of such replacement certificates.

 

G.
Governing Law. All matters between the parties, including without limitation questions
concerning the construction, validity, enforcement and interpretation of the Transaction Documents will be governed by and construed
and enforced in accordance with the laws of the U.S. Virgin Islands, without regard to the principles of conflicts of law that
would require or permit the application of the laws of any other jurisdiction, except for corporation law matters applicable to
Company which will be governed by the corporate law of its jurisdiction of formation. The parties hereby waive all rights to a
trial by jury. In any action, arbitration or proceeding, including appeal, arising out of or relating to any of the Transaction
Documents or otherwise involving the parties, the prevailing party will be awarded its reasonable attorneys’ fees and other
costs and expenses reasonably incurred in connection with the investigation, preparation,
prosecution or defense of such action or proceeding.

 

H.
Arbitration. Any dispute, controversy, claim or action of any kind arising out of, relating
to, or in connection with this Agreement, or in any way involving Company and Investor or their respective Affiliates, including
any issues of arbitrability, will be resolved solely by final and binding arbitration in English before a retired judge at JAMS,
or its successor, in the Territory of the Virgin Islands, pursuant to the most expedited and Streamlined Arbitration Rules and
Procedures available. Any interim or final award may be entered and enforced by any court of competent jurisdiction. The final
award will include the prevailing party’s reasonable arbitration, expert witness and attorney fees, costs and expenses.
Notwithstanding the foregoing, Investor may in its sole discretion bring an action in aid of arbitration or for temporary, preliminary
or provisional relief pending completion of arbitration.

 

    	19

    	 

    

 

I.
Payment Set Aside. To the extent that Company makes a payment or payments to Investor
pursuant to any Transaction Document or Investor enforces or exercises its rights thereunder, and such payment or payments or
the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential,
set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to Company, a trustee, receiver
or any other person under any law, including, without limitation, any bankruptcy law, state or federal law, common law or equitable
cause of action, then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied
will be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had
not occurred.

 

J.
Headings. The titles and headings in
this Agreement and the Transaction Documents are for convenience only, do not constitute a part of this Agreement and will not
be deemed to limit or affect any of the provisions hereof

 

K.
Time of the Essence. Time is of the essence with respect to all provisions of this Agreement,
the Note, and all Transaction Documents.

 

L.
Survival. The representations and warranties contained herein will survive the Closing
and the delivery of the Note and Shares until the entire Note issued to Investor has been converted or redeemed. Neither party
will be under any obligation to update or supplement any of its representations or warranties following the Closing due to a change
that occurred after the Closing.

 

M.
Construction. The parties agree that each
of them and/or their respective counsel has reviewed and had an opportunity to revise the Transaction Documents and, therefore,
the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party will not be employed
in the interpretation of the Transaction Documents or any amendments hereto. The
language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no
rules of strict construction will be applied against any party. All currency references in any Transaction Document are to U.S.
dollars.

 

N.
Further Assurances. Each party will take all further actions and execute all further
documents as may be reasonably necessary to implement the provisions and carry out the intent of this Agreement fully and effectively.

 

O.
Execution. This Agreement may be executed in two or more counterparts, all of which when
taken together will be considered one and the same agreement and will become effective when counterparts have been signed by each
party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event
that any signature is delivered by portable document format, facsimile or electronic transmission, such signature will create
a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and
effect as if such signature page were an original thereof.

 

P.
Entire Agreement. This Agreement, including the Exhibits hereto,
which are hereby incorporated herein by reference, contains the entire agreement and understanding of the parties,
and supersedes all prior and contemporaneous agreements, term sheets, letters,
discussions, communications and understandings, both oral and written, which
the parties acknowledge have been merged into this Agreement. No party, representative, advisor, attorney or agent has
relied upon any collateral contract, agreement, assurance, promise, understanding, statement or representation not expressly set
forth herein. The parties hereby absolutely, unconditionally and irrevocably waive all rights and remedies, at law and in equity,
directly or indirectly arising out of or relating to, or which may arise as a result of, any Person’s reliance on any such
statement or assurance.

 

    	20

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized signatories
on the Effective Date.

 

Company:

 

	INCEPTION
    MINING, INC.	 
	 	 
	By:	/s/
    Trent D’Ambrosio	 
	Name:
    	Trent
    D’Ambrosio	 
	Title:
    	Chief
    Executive Officer	 

 

Investor:

 

	/s/	 
	Investor
    Name	 
	 	 
	By:	/s/	 

 

    	21

    	 

    

 

Exhibit
1

 

Glossary
of Defined Terms

 

“$”
means the currency of the United States of America, in which all dollar amounts in the Transaction Documents will be expressed.

 

“Act”
means the U.S. Securities Act of 1933, as amended, and the rules and regulations promulgated by the Commission thereunder.

 

“Action”
has the meaning set forth in Section III.A.4.

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common
control with a Person, as such terms are used in and construed under Rule 144 under the Act.

 

“Agreement”
means this Note Purchase Agreement.

 

“Closing”
has the meaning set forth in Section II.D.

 

“Commission”
means the U.S. Securities and Exchange Commission.

 

“Common
Stock” means the Common Stock of Company and any replacement or substitute thereof, or any share capital into which
such Common Stock will have been changed or any share capital resulting from a reclassification of such Common Stock.

 

“Company”
has the meaning set forth in the first paragraph of the Agreement.

 

“Conversion
Shares” includes all shares of Common Stock potentially issuable in relation to the Note, including Common Stock that
must be issued upon conversion of the Note, and Common Stock that must or may be issued in payment of any Interest or Conversion
Premium.

 

“Disclosure
Schedules” means the disclosure schedules of Company attached hereto as Exhibit 9. The Disclosure Schedules contain
no material non-public information.

 

“DTC”
means The Depository Trust Company, or any successor performing substantially the same function for Company.

 

“Exchange
Act” means the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated by the Commission
thereunder.

 

“Effective
Date” has the meaning set forth in the first paragraph of the Agreement.

 

“Equity
Conditions” has the meaning set forth in the Note.

 

    	1

    	 

    

 

“GAAP”
means U.S. generally accepted accounting principles applied on a consistent basis during the periods involved.

 

“Indebtedness”
means (a) any liabilities for borrowed money or amounts owed in excess of $250,000, other than trade accounts payable incurred
in the ordinary course of business, (b) all guaranties, endorsements and other contingent obligations in respect of Indebtedness
of others, whether or not the same are or should be reflected in Company’s
balance sheet, or the notes thereto, except guaranties by endorsement of negotiable instruments for deposit or collection or similar
transactions in the ordinary course of business; and (c) the present value of any lease payments in excess of $250,000 due under
leases required to be capitalized in accordance with GAAP.

 

“Intellectual
Property Rights” has the meaning set forth in Section III.B.11.

 

“Investor”
has the meaning set forth in the first paragraph
of the Agreement.

 

“Legal
Opinion” means an opinion from Company’s legal counsel, in the form attached as Exhibit 4.

 

“Liens”
means a lien, charge, security interest or encumbrance in excess of $250,000, or a right of first refusal, preemptive right
or other restriction.

 

“Material
Adverse Effect” includes any material adverse effect on (a) the legality, validity or enforceability of any Transaction
Document, (b) the results of operations, assets, business, or financial condition of Company and the Subsidiaries, taken as a
whole, which is not disclosed in the Public Reports prior to the Effective Date, (c) Company’s ability to perform in any
material respect on a timely basis its obligations under any Transaction Document, or (d) the sale, issuance, registration, listing,
resale and trading on the Trading Market of the Conversion Shares.

 

“Material
Permits” has the meaning set forth in Section III.B.9.

 

“Note”
means the Senior Secured Subordinated Note issued by Company, in the form attached as Exhibit 2.

 

“Officer’s
Certificate” means a certificate executed by an authorized officer of Company, in the form attached as Exhibit 5.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited
liability company, joint stock company, government, or an agency or subdivision thereof, or other entity of any kind.

 

“Prospectus”
means the final prospectus filed for the Registration Statement.

 

“Prospectus
Supplement” means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is timely filed
with the Commission and delivered by the Company to Investor.

 

    	2

    	 

    

 

“Public
Deed” means a Public Deed securing full and timely performance of all obligations under the Transaction Documents, as
registered in the applicable registries in Honduras, in the form attached hereto as Exhibit 8.

 

“Public
Reports” means the reports filed with the Commission by the Company pursuant to the Exchange Act (see Exhibit 9).

 

“Purchase
Amount” has the meaning set forth in
Section II.A.1.

 

“Receivables”
include all accounts receivable and all rights to the payment of a monetary obligation, whether or not earned by performance,
and whether evidenced by an account, chattel paper, instrument, general intangible, or otherwise.

 

“Registration
Statement” means a valid, current and effective Registration Statement registering all Shares for sale, including the
prospectus therein, amendments and supplements to such Registration Statement or prospectus, including pre- and post-effective
amendments, all exhibits thereto, and all material incorporated by reference or deemed to be incorporated by reference in such
registration statement, and any information contained or incorporated by reference in a prospectus filed with the Commission in
connection with the Registration Statement, to the extent such information is deemed under the Act to be part of any registration
statement.

 

“Secretary’s
Certificate” means a certificate, in the form attached as Exhibit 6, signed by the secretary of Company.

 

“Shares”
include the Conversion Shares and the Warrant Shares.

 

“Short
Sale” means a “short sale” as defined in Rule 200 of Regulation SHO of the Exchange Act.

 

“Subsidiary”
means any Person owned or controlled by the Company, or in which Company, directly or indirectly, owns a majority of the capital
stock or similar interest that would be disclosable pursuant to Regulation S-K, Item 601(b) (21).

 

“Trading
Day” means any day on which the Common Stock is traded on the Trading Market; provided
that it will not include any day on which the Common Stock is (a) scheduled to trade for less than 5 hours, or (b) suspended from
trading.

 

“Trading
Market” has the meaning set forth in the Note.

 

“Transaction
Documents” means this Agreement, the Note, the Warraant, the other agreements, certificates and documents referenced
herein or the form of which is attached hereto, and the exhibits, schedules and appendices hereto and thereto.

 

“Transfer
Agent” means the current and any future transfer agent for Company.

 

“Transfer
Agent Instructions” means a letter agreement executed by Company, its current transfer agent, and any successor transfer
agent for the Common Stock, in the form attached as Exhibit 3.

 

“Warrant”
means the Warrant to Purchase Common Stock in the form attached hereto as Exhibit 7.

 

“Warrant
Shares” includes all shares of Common Stock potentially issuable in relation to the Warrant.

 

    	3Ex.
10.16

 

Note

 

INCEPTION
MINING, INC.

 

SENIOR
SECURED REDEEMABLE CONVERTIBLE NOTE

 

I.
Terms of Note.

 

A.
Designation and Amount. This Senior Secured Redeemable Convertible Note (“Note”) is issued and delivered
to the holder of this Note (each, a “Investor” and collectively, the “Investors”), or order,
by Inception Mining, Inc., a Nevada corporation (“Company”), in the aggregate face value of $4,250,000.00 (“Face
Value”) on May 20, 2019 (“Issuance Date”). The Company will pay the Face Value to Investor in full
on the Maturity Date.

 

B.
Ranking. This Note will rank senior to all common stock, preferred stock, existing and future indebtedness of the Company.

 

C.
Interest.

 

1.
Commencing on the Issuance Date, this Note will accrue compound interest (“Interest”) at a rate equal to
10% per annum, subject to adjustment as provided in this Note (“Interest Rate”), of the Face Value. The Interest
Rate will retroactively increase by 10% per annum upon each occurrence of any Trigger Event (e.g. to 20% upon the first Trigger
Event). Interest will be payable with respect to any portion of the Face Value of the Note upon any of the following: (a) upon
redemption of the Note in accordance with Section I.F; (b) upon conversion of all or any portion of the Note in accordance
with Section I.G, only with respect to that portion which is converted; (c) when, as and if otherwise declared by the board
of directors of the Company; and (d) the Maturity Date. The Interest Rate used for calculation of the Liquidation Value, Early
Redemption Price and Accrual, as applicable, and the amount of Interest owed will be calculated and determined at close of the
Trading Market immediately prior to the Notice Time.

 

2.
Interest, as well as any applicable Liquidation Value or Conversion Premium payable hereunder, will be paid: (a) provided
no Trigger Event has occurred, in the Company’s sole and absolute discretion, immediately in cash; or (b) following the
occurrence of a Trigger Event, or if Company does not for any reason whatsoever timely notify and pay Investor as provided in
Section I.G.1.c below, in shares of Common Stock valued at the Conversion Price. All amounts that are required or permitted
to be paid in cash pursuant to this Note will be paid by wire transfer of immediately available funds to an account designated
by Investor.

 

3.
So long as any portion of this Note is outstanding, the Company will not repurchase shares of Common Stock other than as payment
of the exercise or conversion price of a convertible security or payment of withholding tax, and no dividends or other distributions
will be paid, declared or set apart with respect to any Common Stock, except for Purchase Rights.

 

    	 	1	 

    	 	 	 

    

 

D.
Protective Provision.

 

1.
So long as any portion of this Note is outstanding, the Company will not, without written approval of the Investor, alter
or amend this Note.

 

2.
A “Deemed Liquidation Event” will mean: (a) a merger or consolidation in which the Company is a constituent
party or a subsidiary of the Company is a constituent party and the Company issues shares of its capital stock pursuant to such
merger or consolidation, except any such merger or consolidation involving the Company or a subsidiary in which the shares of
capital stock of the Company outstanding immediately prior to such merger or consolidation continue to represent, or are converted
into or exchanged for shares of capital stock that represent, immediately following such merger or consolidation, at least a majority,
by voting power, of the capital stock of the surviving or resulting corporation or if the surviving or resulting corporation is
a wholly owned subsidiary of another corporation immediately following such merger or consolidation, the parent corporation of
such surviving or resulting corporation; (b) Company issues securities that are senior to the Note in any respect, (c) Investor
does not receive the number of Conversion Shares stated in a Conversion Notice with 5 Trading Days of the Notice Time; (d) trading
of the Common Stock is halted or suspended by the Trading Market or any U.S. governmental agency for 5 or more consecutive trading
days; or (e) the sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions,
by the Company or any subsidiary of the Company of all or substantially all the assets of the Company and its subsidiaries taken
as a whole, or the sale or disposition (whether by merger or otherwise) of one or more subsidiaries of the Company if substantially
all of the assets of the Company and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries.

 

3.
The Company will not have the power to close or effect a voluntary Deemed Liquidation Event unless the agreement or plan of
merger or consolidation for such transaction provides that the consideration payable to the stockholders of the Company will be
allocated among the holders of capital stock of the Company in accordance with Section I.E, and the required amount is
paid to Investor prior to or upon closing, effectuation, or occurrence of the Deemed Liquidation Event.

 

E.
Liquidation.

 

1.
Upon any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, prior to any distribution
or payment made to any other creditors or the holders of any Preferred Stock or Common Stock by reason of their ownership thereof,
the Investor will be entitled to be paid out of the assets of the Company available for distribution to its creditors an amount
with respect to the then-outstanding Face Value, plus an amount equal to any accrued but unpaid Interest thereon (collectively
with the Face Value, the “Liquidation Value”). If, upon any liquidation, dissolution or winding up of the Company,
whether voluntary or involuntary, the amounts payable with respect to the Note are not paid in full, the Investors will share
equally and ratably in any distribution of assets of the Company in proportion to the liquidation preference and an amount equal
to all accumulated and unpaid Interest, if any, to which each such Investor is entitled.

 

    	 	2	 

    	 	 	 

    

 

F.
Redemption.

 

1.
Company’s Redemption Option. On the Maturity Date, the Company
may redeem the Note by paying Investor in cash an amount equal to 100% of the Liquidation Value.

 

2.
Early Redemption. Prior to the Maturity Date, provided that no Trigger Event has occurred, the Company will have the
right at any time upon 30 Trading Days’ prior written notice, in its sole and absolute discretion, to redeem all or any
portion of the Note then outstanding by paying Investor in cash by wire transfer of immediately available funds an amount (the
“Early Redemption Price”) equal to 140% of the then-outstanding Face Value.

 

4.
Mandatory Redemption. If the Company determines to liquidate, dissolve or wind-up its business and affairs, or effect
any Deemed Liquidation Event, the Company will, within three Trading Days of such determination and prior to effectuating any
such action, redeem this Note for cash, by wire transfer of immediately available funds to an account designated by Investor,
at the Early Redemption Price set forth in Section I.F.2 if the event is prior to the Maturity Date, or at the Liquidation
Value if the event is on or after the Maturity Date.

 

5.
Mechanics of Redemption. In order to redeem any portion of this Note then outstanding, 30 Trading Days prior to payment
the Company must deliver written notice (each, a “Redemption Notice”) to Investor setting forth (a) the Face
Value the Company is redeeming, (b) the applicable Interest Rate, Liquidation Value and Early Redemption Price, and (c) the calculation
of the amount paid. Upon receipt of full payment in cash for the entire Note, the Investor will promptly submit to the Company
the Note. For the avoidance of doubt, the delivery of a Redemption Notice shall not affect Investor’s rights under Section
I.G until after receipt of cash payment by Investor.

 

G.
Conversion.

 

1.
Mechanics of Conversion.

 

a.
All or any portion of the Face Value of the Note may be converted, in part or in whole, into shares of Common Stock, at any
time or times after the Issuance Date, in the sole and absolute discretion of Investor or, subject to the terms and conditions
hereof, the Company; (i) if at the option of Investor, by delivery of one or more written notices to the Company or its transfer
agent (each, a “Investor Conversion Notice”), of the Investor’s election to convert any or all of the
Note or (ii) if at the option of the Company, if the Equity Conditions are met, delivery of written notice to Investor (each,
a “Company Conversion Notice” and, with the Investor Conversion Notice, each a “Conversion Notice”),
of the Company’s election to convert all of any portion of the Note.

 

b.
Each Delivery Notice (as defined below) will set forth the amount of Face Value of Note being converted, the Conversion Premium,
and the minimum number of Conversion Shares due as of the time the Delivery Notice is given (the “Notice Time”),
and the calculation thereof. The Company has a right to request clarification and explanation on Delivery Notices that are not
legally sufficient or do not satisfy the provisions of relevant laws.

 

    	 	3	 

    	 	 	 

    

 

c.
As soon as practicable, and in any event within 1 Trading Day after the Notice Date, time being of the essence, the Company
will do all of the following: (i) transmit the Delivery Notice by facsimile or electronic mail to the Company’s transfer
agent (the “Transfer Agent”), copying Investor, with instructions to immediately comply with the Delivery Notice
and deliver the number of Conversion Shares stated in the Delivery Notice forthwith; (ii) either (A) if the Company is approved
through The Depository Trust Company (“DTC”), authorize and instruct the credit by the Transfer Agent of the
number of Conversion Shares set forth in the Delivery Notice, to Investor’s or its designee’s balance account with
the DTC Fast Automated Securities Transfer (FAST) Program, through its Deposit/Withdrawal at Custodian (DWAC) system, or (B) only
if the Company is not approved through DTC, issue and surrender to a common carrier for overnight delivery to the address as specified
in the Delivery Notice a certificate bearing no restrictive legend, registered in the name of Investor or its designee, for the
number of Conversion Shares set forth in the Delivery Notice; and (iii) if it contends that the Delivery Notice is in any way
incorrect, so notify Investor and provide a thorough written explanation and its own calculation, or the Delivery Notice and the
calculations therein will conclusively be deemed correct for all purposes. The Company will at all times diligently take or cause
to be taken all actions necessary to cause the Conversion Shares to be issued forthwith. If the Conversion Shares are not registered
for resale, Investor will provide a legal opinion that they are exempt from registration. Under no circumstances will the Company
issue a share certificate bearing a restrictive legend.

 

d.
If during or at the end of the Measuring Period the Investor is entitled to receive additional Conversion Shares with regard
to an Initial Notice, Investor may at any time deliver one or more additional written notices to the Company or its transfer agent
(each, an “Additional Notice” and with the Initial Notice, each a “Delivery Notice”) setting
forth the additional number of Conversion Shares to be delivered, and the calculation thereof.

 

e.
If the Company for any reason does not issue or cause to be issued to the Investor within 3 Trading Days after the date of
a Delivery Notice, the number of Conversion Shares stated in the Delivery Notice, then, in addition to all other remedies available
to the Investor, as liquidated damages and not as a penalty, the Company will pay in cash to the Investor on each day after such
2nd Trading Day that the issuance of such Conversion Shares is not timely effected an amount equal to 2% of the product of (i)
the aggregate number of Conversion Shares not issued to the Investor on a timely basis and to which the Investor is entitled and
(ii) the highest Closing Price of the Common Stock between the date on which the Company should have issued such shares to the
Investor and the actual date of receipt of Conversion Shares by Investor. It is intended that the foregoing will serve to reasonably
compensate Investor for any delay in delivery of Conversion Shares, and not as punishment for any breach by the Company. The Company
acknowledges that the actual damages likely to result from delay in delivery are difficult to estimate and would be difficult
for Investor to prove.

 

f.
Notwithstanding any other provision: all of the requirements of Section I.F and this Section I.G are each independent
covenants; the Company’s obligations to issue and deliver Conversion Shares upon any Delivery Notice are absolute, unconditional
and irrevocable; any breach or alleged breach of any representation or agreement, or any violation or alleged violation of any
law or regulation, by any party or any other person will not excuse full and timely performance of any of the Company’s
obligations under these sections; and under no circumstances may the Company seek or obtain any temporary, interim or preliminary
injunctive or equitable relief to prevent or interfere with any issuance of Conversion Shares to Investor.

 

    	 	4	 

    	 	 	 

    

 

g.
Company acknowledges and agrees that monetary damages would be difficult to quantify and prove, and that Investor would not
have an adequate remedy at law for any failure to fully perform under this Section G. If for any reason whatsoever Investor
does not timely receive the number of Conversion Shares stated in any Delivery Notice, Investor will be entitled to a compulsory
remedy of immediate specific performance, temporary, interim and, preliminary and final injunctive relief requiring Company and
its transfer agent, attorneys, officers and directors to immediately issue and deliver the number of Conversion Shares stated
by Investor, which requirement will not be stayed for any reason, without the necessity of posting any bond, and which Company
may not seek to stay or appeal.

 

h.
No fractional shares of Common Stock are to be issued upon conversion of this Note, but rather the Company will round up to
the nearest full share. The Investor will not be required to deliver the original of this Note in order to effect a conversion
hereunder. The Company will pay any and all taxes which may be payable with respect to the issuance and delivery of any Conversion
Shares.

 

2.
Investor Conversion. In the event of a conversion of any portion of this Note pursuant to a Investor Conversion Notice,
the Company will (a) satisfy the payment of Conversion Premium as provided in Section I.C.2, and (b) issue to the Investor
of this Note a number of Conversion Shares equal to the Face Value divided by the applicable Conversion Price with respect to
the amount of Note converted; all in accordance with the procedures set forth in Section I.G.1.

 

3.
Company Conversion. The Company will have the right to send the Investor a Company Conversion Notice at any time in
its sole and absolute discretion, if the Equity Conditions are met as of the time such Company Conversion Notice is given. Upon
any conversion of any portion of this Note pursuant to a Company Conversion Notice, the Company will on the date of such notice
(a) satisfy the payment of Conversion Premium as provided in Section I.C.2, and (b) issue to the Investor of this Note
a number of Conversion Shares equal to the Face Value divided by the applicable Conversion Price with respect to the amount of
Note converted; all in accordance with the procedures set forth in Section I.G.1.

 

4.
Stock Splits. If the Company at any time on or after the issuance of this Note subdivides (by any stock split, stock
dividend, recapitalization or otherwise) one or more classes of its outstanding shares of Common Stock into a greater number of
shares, the applicable Conversion Price, Adjustment Factor, Maximum Triggering Level, Minimum Triggering Level, and other share
based metrics in effect immediately prior to such subdivision will be proportionately reduced and the number of shares of Common
Stock issuable will be proportionately increased. If the Company at any time on or after such Issuance Date combines (by combination,
reverse stock split or otherwise) one or more classes of its outstanding shares of Common Stock into a smaller number of shares,
the applicable Conversion Price, Adjustment Factor, Maximum Triggering Level, Minimum Triggering Level, and other share based
metrics in effect immediately prior to such combination will be proportionately increased and the number of Conversion Shares
will be proportionately decreased. Any adjustment under this Section will become effective at the close of business on the date
the subdivision or combination becomes effective.

 

    	 	5	 

    	 	 	 

    

 

5.
Rights. In addition to any other adjustments, if at any time the Company grants, issues or sells any options, convertible
securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of
shares of Common Stock (the “Purchase Rights”), then Investor will be entitled to acquire, upon the terms applicable
to such Purchase Rights, the aggregate Purchase Rights which Investor could have acquired if Investor had held the number of shares
of Common Stock acquirable upon conversion of the entire Note held by Investor immediately before the date on which a record is
taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record
holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights.

 

6.
Definitions. The following terms will have the following meanings:

 

a.
“Agreement” means the Note Purchase Agreement or other agreement pursuant to which the Note is issued,
including all exhibits thereto and all related Transaction Documents as defined therein.

 

b.
“Collateral” means all assets of the Company, including without limitation all personal property wherever located,
both now owned and hereafter acquired, including, but not limited to, all equipment, fixtures, inventory, goods, documents, general
intangibles, accounts, deposit accounts (unless a security interest would render a nontaxable account taxable), receivables, contract
rights (including, but not limited to, all of Company’s rights in franchise agreements, license agreements and market development
agreements), chattel paper, patents, trademarks and copyrights (and the good will associated with and registrations and licensing
of them), instruments, letter of credit rights and investment property, capital stock, partnership, membership and equity interests,
of any kind or nature, and all additions and accessions to, all spare and repair parts, special tools, equipment and replacements
for, software used in, all returned or repossessed goods the sale of which gave rise to, and all accessions, additions, amendments,
modifications, replacements, and substitutions to, of or for the foregoing, and all proceeds, supporting obligations and products
of the foregoing, except as set forth in the Disclosure Schedules. All terms which are used in this definition which are defined
in the UCC shall have the same meanings herein as such terms are defined in the UCC, unless this Note shall otherwise specifically
provide.

 

c.
“Conversion Premium” with respect to any amount of this Note that is converted prior to the Maturity Date
means the Face Value of the amount converted, multiplied by the product of (i) the applicable Interest Rate, and (ii) the number
of whole years between the Issuance Date and the Maturity Date.

 

d.
“Conversion Price” means, if there has never been a Trigger Event, a price per share of Common Stock equal
to 100% of the Market Price less $0.01 per share, subject to adjustment as otherwise provided herein. Upon the occurrence of each
Trigger Event the percentage in the preceding sentence will decrease by 10% (e.g. to 90% upon the first Trigger Event). In no
event will the Conversion Price be less than the par value per share.

 

    	 	6	 

    	 	 	 

    

 

e.
“Conversion Shares” means all shares of Common Stock that are required to be or may be issued upon conversion
of this Note.

 

f.
“Equity Conditions” means on each day during the Measuring Period, (i) the Common Stock is not under chill
or freeze from DTC, (ii) the Common Stock is designated for trading on a OTCQB or higher stock market and shall not have been
suspended from trading on such market, and delisting or suspension by the Trading Market has not been threatened or pending, either
in writing by such market or because Company has fallen below the then effective minimum listing maintenance requirements of such
market; (iii) the Company has delivered Conversion Shares upon all conversions or redemptions of this Note in accordance with
their terms to the Investor on a timely basis; (iv) the Company will have no knowledge of any fact that would cause both of the
following (A) a registration statement not to be effective and available for the resale of all Conversion Shares, and (B) Section
3(a)(9) under the Securities Act of 1933, as amended, not to be available for the issuance of all Conversion Shares, or Securities
Act Rule 144 not to be available for the resale of all the Conversion Shares without restriction; (v) there has been a minimum
of 5 times the amount of Face Value of the Note then being converted by the Company in aggregate trading volume in the prior 20
Trading Days; (vi) all shares of Common Stock to which Investor is entitled have been timely received into Investor’s designated
account in electronic form fully cleared for trading; (vi) the Company otherwise shall have been in compliance with and shall
not have breached any provision, covenant, representation or warranty of any Transaction Document; and (vii) not more than 3 Trigger
Events shall have occurred.

 

g.
“Floor Price” means $0.01 per share of Common Stock. The Conversion Price will not be below the Floor Price.

 

h.
“Maturity Date” means the date that is the 2-year anniversary of the Issuance Date.

 

i.
“Market Price” means the mathematical average of the 5 lowest individual daily volume weighted average
prices of the Common Stock during the Measuring Period, which may be non-consecutive.

 

j.
“Measuring Period” means the period beginning on the Issuance Date and ending on the Maturity Date.

 

k.
“Obligations” include the full and punctual observance and performance
of all present and future duties, covenants, and responsibilities due to Investor by Company under this Note, the Agreement, and
the other Transaction Documents, including without limitation all present and future obligations and liabilities of Company for
the payment of money (extending to all principal amounts, interest, late charges, fees, and all other charges and sums, as well
as all costs and expenses payable by Company).

 

l.
“Trading Day” means any day on which the Common Stock is traded on the Trading Market.

 

    	 	7	 

    	 	 	 

    

 

m.
“Trading Market” means OTCQB or whatever higher market is at the applicable time, the principal U.S. trading
exchange or market for the Common Stock. All Trading Market data will be measured as provided by the appropriate function of the
Bloomberg Professional service of Bloomberg Financial Markets or its successor performing similar functions.

 

n.
“UCC” means the Uniform Commercial Code as adopted and applied in any applicable jurisdiction, including
without limitation Company’s jurisdiction of formation

 

7.
Issuance Limitation. Notwithstanding any other provision, at no time may the Company issue shares of Common Stock to
Investor which, when aggregated with all other shares of Common Stock then deemed beneficially owned by Investor, would result
in Investor owning more than 4.99% of all Common Stock outstanding immediately after giving effect to such issuance, as determined
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder; provided, however,
that Investor may increase such amount to 9.99% upon not less than 61 days’ prior notice to the Company. Company and its
transfer agent will immediately provide Investor with the then total number of outstanding shares of Common Stock at any time
upon request. No provision of this paragraph may be waived by Investor or the Company.

 

8.
Conversion at Maturity. Subject to the foregoing paragraph and provided no Trigger Event has occurred, if Company does
not redeem this Note as set forth in Section I.F.2, at close of business on the Maturity Date the full remaining outstanding
Note will be automatically converted into shares of Common Stock at the Conversion Price.

 

H.
Trigger Event.

 

1.
Any occurrence of any one or more of the following, at any time and for any reason whatsoever, will constitute a “Trigger
Event”:

 

a.
Investor does not timely receive the number of Conversion Shares stated in any Conversion Notice, time being of the essence;

 

b.
The issuance of restricted shares if Investor provides a legal opinion that shares may be issued without restrictive legend,
or the issuance of a certificate if Investor requests electronic delivery via DTC;

 

c.
Any violation of or failure to timely perform any covenant or provision of this Note, the Agreement, or any Transaction Document,
related to payment of cash, registration, authorization, reservation, issuance or delivery of Conversion Shares, time being of
the essence;

 

d.
Any violation of or failure to perform any covenant or provision of this Note, the Agreement, or any Transaction Document,
which in the case of a default that is curable, is not related to payment of cash, registration, reservation or delivery of Conversion
Shares, and has not occurred before, is not cured within 5 Trading Days of written notice thereof;

 

e.
Any representation or warranty made in the Agreement or any Transaction Document is untrue or incorrect in any respect as
of the date when made or deemed made;

 

    	 	8	 

    	 	 	 

    

 

f.
The occurrence of any default or event of default under any material agreement, lease, document or instrument to which the
Company or any subsidiary is obligated with a value of $250,000 or more, including without limitation of an aggregate of at least
$250,000 of indebtedness, not disclosed in the Disclosure Schedules;

 

g.
While any Registration Statement is required to be maintained effective pursuant to any Transaction Document, the effectiveness
of the Registration Statement lapses for any reason, including, without limitation, the issuance of a stop order, or the Registration
Statement, or the prospectus contained therein, is unavailable to Investor sale of all Conversion Shares for any 10 or more Trading
Days, which may be non-consecutive;

 

h.
The suspension from trading or the failure of the Common Stock to be trading or listed on the Trading Market, or failure to
meet the requirements for continued listing on the Trading Market;

 

i.
The Company’s notice, written or oral, to Investor, including without limitation, by way of public announcement or through
any of its attorneys, agents, or representatives, of its intention not to comply, as required, with a Conversion Notice at any
time, including without limitation any objection or instruction to its transfer agent not to comply with any notice from Investor;

 

j.
Bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings for the relief of debtors shall be
instituted by or against the Company or any subsidiary and, if instituted against the Company or any subsidiary by a third party,
an order for relief is entered or the proceedings are not dismissed within 30 days of their initiation;

 

k.
The appointment of or taking possession by a custodian, receiver, liquidator, assignee, trustee, or other similar official
of the Company or any subsidiary or of any substantial part of its property, or the making by it of an assignment for the benefit
of creditors, or the execution of a composition of debts, or the occurrence of any other similar federal, state or foreign proceeding,
or the admission by it in writing of its inability to pay its debts generally as they become due, the taking of corporate action
by the Company or any Subsidiary in furtherance of any such action or the taking of any action by any person to commence a foreclosure
sale or any other similar action under any applicable law;

 

l.
A judgment or judgments for the payment of money aggregating in excess of $250,000 are rendered against the Company or any
of its subsidiaries and are not stayed or satisfied within 30 days of entry;

 

m.
The Company does not for any reason timely comply with any applicable reporting requirement of the Securities Exchange Act
of 1934, as amended, and the regulations promulgated thereunder, including without limitation timely filing when first due all
public reports and filings;

 

n.
Any regulatory, administrative or enforcement proceeding is initiated against Company or any subsidiary (except to the extent
an adverse determination would not have a material adverse effect on the Company’s business, properties, assets, financial
condition or results of operations or prevent the performance by the Company of any material obligation under the Transaction
Documents);

 

    	 	9	 

    	 	 	 

    

 

o.
Any material provision of this Note is at any time for any reason, other than pursuant to the express terms thereof, cease
to be valid and binding on or enforceable against the parties thereto, or the validity or enforceability thereof shall be contested
by any party thereto, or a proceeding shall be commenced by the Company or any subsidiary or any governmental authority having
jurisdiction over any of them, seeking to establish the invalidity or unenforceability thereof, or the Company or any subsidiary
denies that it has any liability or obligation purported to be created under this Note; or

 

p.
The failure of one or more Equity Conditions other than (v).

 

2.
It is intended that all adjustments made following a Trigger Event will serve to reasonably compensate Investor for the change
in circumstances, potential consequences and increased risk in light of the occurrence of a Trigger Event, and not as a penalty
or punishment for any breach by the Company. The Company acknowledges that the actual damages likely to result from a Trigger
Event are difficult to estimate and would be difficult for Investor to prove.

 

II.
Security Agreement.

 

A.
Grant of Security Interest. To secure the Obligations, Company, as debtor, hereby assigns and grants to Investor, as
secured party, a continuing first-position lien on and security interest in, all right, title and interest of the Company, whether
now owned or existing or hereafter created, acquired, or arising, in and to all of the Collateral.

 

B.
Change in Name or Locations. Company’s legal name and jurisdiction of organization are correctly set forth in
the Public Reports. Company has not transacted business at any time during the immediately preceding five-year period, and does
not currently transact business, under any other legal names or trade names. Company’s chief executive office and principal
place of business is at, and the Company keeps and shall keep all of its books and records relating to receivables only at the
location identified in the Public Reports, and the Company has no other executive offices or places of business. Company hereby
agrees that if the location of the Collateral changes from the locations it is currently located in, or if Company changes its
name or form or jurisdiction of organization, or establishes a name in which it may do business, Company will immediately notify
Investor in writing of the additions or changes.

 

C.
Representations and Warranties. Company represents, warrants and covenants to Investor that: (a) Company has good,
marketable and indefeasible title to the Collateral, except as disclosed in the Disclosure Schedules, has not made any prior sale,
pledge, encumbrance, assignment or other disposition of any of the Collateral, and except as disclosed in the Disclosure Schedules,
the Collateral is free from all encumbrances and rights of setoff of any kind except the lien in favor of Investor created by
this Agreement; (b) except as herein provided, Company will not hereafter without Investor’s prior written consent sell,
pledge, encumber, assign or otherwise dispose of any of the Collateral or permit any right of setoff, lien or security interest
to exist thereon except to Investor, except for dispositions of Collateral in the ordinary course of business; (c) Company will
defend the Collateral against all claims and demands of all persons at any time claiming the same or any interest therein; and
(d) Company has provided a true, complete, and current listing of all patents, trademarks, tradestyles, copyrights, and other
intellectual property rights (including all registrations and applications therefor) owned by Company as of the date hereof that
are registered with any governmental authority. Company shall promptly notify Investor in writing of any additional intellectual
property rights acquired or arising after the date hereof, and shall submit to the Investor a supplement to reflect such additional
rights, provided Company’s failure to do so shall not impair the Investor’s security interest therein.

 

    	 	10	 

    	 	 	 

    

 

D.
Covenants. Company covenants that it will:

 

(i)
from time to time and at all reasonable times allow Investor, by or through any of its officers, agents, attorneys, or accountants,
to examine or inspect the Collateral, and obtain valuations and audits of the Collateral, at Investor’s expense, wherever
located. Company shall do, obtain, make, execute and deliver all such additional and further acts, things, deeds, assurances and
instruments as Investor may require to assure to Investor its rights hereunder and in or to the Collateral, and the proceeds thereof,
including waivers from landlords, warehousemen and mortgagees;

 

(ii)
keep the Collateral in good order and repair consistent with commercially reasonable past practices at all times and immediately
notify Investor of any event causing a material loss or decline in value of the Collateral, whether or not covered by insurance,
and the amount of such loss or depreciation;

 

(iii)
only use or permit the Collateral to be used in accordance with all applicable federal, state, county and municipal laws and regulations;

 

(iv)
to the extent applicable, have and maintain insurance at all times with respect to all Collateral against risks of fire (including
so called extended coverage), theft, sprinkler leakage, and other risks (including risk of flood if any Collateral is maintained
at a location in a flood hazard zone) as Investor may reasonably require, in such form, in the minimum amount of the outstanding
principal of the Note and written by such companies as may be reasonably satisfactory to Investor; each such casualty insurance
policy shall contain a standard Investor’s Loss Payable Clause issued in favor of Investor under which all losses thereunder
shall be paid to Investor as Investor’s interest may appear; such policies shall expressly provide that the requisite insurance
cannot be altered or canceled without at least thirty (30) days prior written notice to Investor and shall insure Investor notwithstanding
the act or neglect of Company; upon Investor’s demand, Company shall furnish Investor with evidence of insurance as Investor
may reasonably require; in the event of failure to provide insurance as herein provided, Investor may, at its option, obtain such
insurance and Company shall pay to Investor, on demand, the cost thereof; proceeds of insurance may be applied by Investor to
reduce the Obligations or to repair or replace Collateral, all in Investor ‘s sole discretion;

 

(v)
If any of the Collateral is, at any time, in the possession of a bailee, Company will promptly notify Investor thereof and, if
requested by Investor, shall promptly obtain an acknowledgment from the bailee, in form and substance satisfactory to Investor,
that the bailee holds such Collateral for the benefit of Investor and shall act upon the instructions of Investor, without the
further consent of Company;

 

    	 	11	 

    	 	 	 

    

 

(vi)
Company will not change its legal name or transact business under any other trade name without first giving 30 days’ prior
written notice of its intent to do so to the Investor; and

 

(vii)
Company will promptly pay when due all taxes, assessments and governmental charges and levies upon or against Company or any of
the Collateral, in each case before the same become delinquent and before penalties accrue thereon, unless and to the extent that
the same are being contested in good faith by appropriate proceedings which prevent foreclosure or other realization upon any
of the Collateral and preclude interference with the operation of Company’s business in the ordinary course, and Company
shall have established adequate reserves therefor.

 

E.
Negative Pledge; No Transfer. Company will not sell or offer to sell or otherwise transfer or grant or allow the imposition
of a lien, encumbrance or security interest of any kind upon the Collateral or use any portion thereof in any manner inconsistent
with this Agreement or with the terms and conditions of any policy of insurance thereon. The Company shall warrant and defend
the Collateral against any claims and demands of all persons at any time claiming the same or any interest in the Collateral adverse
to the Investor.

 

F.
Further Assurances. Company hereby irrevocably authorizes Investor at any time and from time to time to file in any
UCC jurisdiction any initial financing statements and amendments thereto that (a) indicate the Collateral (i) as all assets of
Company or words of similar effect, regardless of whether any particular asset comprised in the Collateral falls within the scope
of Article 9 of the UCC or such jurisdiction, or (ii) as being of an equal or lesser scope or with greater detail, and (b) contain
any other information required by part 5 of Article 9 of the UCC for the sufficiency or filing office acceptance of any financing
statement or amendment, including, but not limited to (i) whether Company is an organization, the type of organization and (ii)
any organization identification number issued to Company. Company agrees to furnish any such information to Investor promptly
upon request. Company also ratifies its authorization for Investor to have filed in any UCC jurisdiction any like initial financing
statements or amendments thereto if filed prior to the date hereof.

 

G.
Events of Default. Company shall, at Investor’s option, be in default under this Agreement upon the happening
of any of the following events or conditions (each, an “Event of Default”): (a) a failure to pay any amount
due under this Note, the Agreement or any Transaction Document within 5 business days of the date the same is due; (b) the failure
by Company to perform any of its other obligations under this Note, the Agreement or any Transaction Document within 5 business
days of notice from Investor of the same; (c) falsity, inaccuracy or material breach by Company of any written warranty, representation
or statement made or furnished to Investor by or on behalf of Company; (d) an uninsured material loss, theft, damage, or destruction
to any of the Collateral, or the entry of any judgment against Company or any lien against or the making of any levy, seizure
or attachment of or on the Collateral; (e) the failure of Investor to have a perfected first priority security interest in the
Collateral; (f) any indication or evidence received by Investor that Company may have directly or indirectly been engaged in any
type of activity that might reasonably be expected to result in the forfeiture of any property of Company to any governmental
entity, federal, state or local; (g) the Closing Price of the Common Stock is below $0.05 per share for 20 Trading Days or more;
or (h) the occurrence of any 3 or more Trigger Events.

 

    	 	12	 

    	 	 	 

    

 

H.
Remedies. Upon the occurrence of any Event of Default and at any time thereafter, the Floor Price shall no longer apply,
and Investor may declare all Obligations secured hereby immediately due and payable and shall have, in addition to any remedies
provided herein or by any applicable law or in equity, all the remedies of a secured party under the UCC. Investor’s remedies
include, but are not limited to, to the extent permitted by law, the right to (a) peaceably by its own means or with judicial
assistance enter Company’s premises and take possession of the Collateral without prior notice to Company or the opportunity
for a hearing, (b) render the Collateral unusable, (c) dispose of the Collateral on Company’s premises, and (d) require
Company to assemble the Collateral and make it available to Investor at a place designated by Investor. Unless the Collateral
is perishable or threatens to decline speedily in value or is of a type customarily sold on a recognized market, Investor will
give Company reasonable notice of the time and place of any public sale thereof or of the time after which any private sale or
any other intended disposition thereof is to be made. The requirements of commercially reasonable notice shall be met if such
notice is sent to Company at least 5 business days before the time of the intended sale or disposition. Expenses of retaking,
holding, preparing for sale, selling or the like shall include Investor ‘s reasonable attorney’s fees and legal expenses,
incurred or expended by Investor to enforce any payment due it under this Note either as against Company, or in the prosecution
or defense of any action, or concerning any matter growing out of or connection with the subject matter of this Note and the Collateral
pledged hereunder. Company waives all relief from all appraisement or exemption laws now in force or hereafter enacted.

 

I.
Payment of Expenses. At its option, Investor may, but is not required to: discharge taxes, liens, security interests
or such other encumbrances as may attach to the Collateral; pay for required insurance on the Collateral; and pay for the maintenance,
appraisal or reappraisal, and preservation of the Collateral, as determined by Investor to be necessary.

 

J.
Preservation of Rights. No delay or omission on Investor’s part to exercise any right or power arising hereunder
will impair any such right or power or be considered a waiver of any such right or power, nor will Investor’s action or
inaction impair any such right or power. Investor ‘s rights and remedies hereunder are cumulative and not exclusive of any
other rights or remedies which Investor may have under other agreements, at law or in equity.

 

III.
General.

 

V.
General Provisions.

 

A.
Notice. Unless a different time of day or method of delivery is specifically provided
in the Agreement, any and all notices or other communications or deliveries required or permitted to be provided hereunder will
be in writing and will be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication
is delivered via facsimile or electronic mail prior to 5:00 p.m. New York time on a Trading Day and an electronic confirmation
of delivery is received by the sender, (b) the next Trading Day after the date of transmission, if such notice or communication
is delivered later than 5:00 p.m. New York time or on a day that is not a Trading Day, (c) the next Trading Day following the
date of mailing, if sent by U.S. nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom
such notice is required to be given. The addresses for such notices and communications are such other address as may be designated
in writing, in the same manner, by such Person.

 

    	 	13	 

    	 	 	 

    

 

B.
Amendments; Waivers. No provision of this Note may be waived or amended except in a written
instrument signed, in the case of an amendment, by Company and Investor or, in the case of a waiver, by the party against whom
enforcement of any such waiver is sought. No waiver of any default with respect to any provision, condition or requirement of
this Note will be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement hereof, nor will any delay or omission of either party to exercise any right hereunder in
any manner impair the exercise of any such right.

 

C.
No Third-Party Beneficiaries. This Note will inure solely to the benefit of the Investor,
and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

D.
Severability. If any provision of this Note is held to be invalid or unenforceable in
any respect, the validity and enforceability of the remaining terms and provisions of this Note will not in any way be affected
or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute
therefor, and upon so agreeing, will incorporate such substitute provision in this Note.

 

E.
Governing Law. All matters between the parties, including without limitation questions
concerning the construction, validity, enforcement and interpretation of the Transaction Documents will be governed by and construed
and enforced in accordance with the laws of the U.S. Virgin Islands, without regard to the principles of conflicts of law that
would require or permit the application of the laws of any other jurisdiction, except for corporation law matters applicable to
Company which will be governed by the corporate law of its jurisdiction of formation. The parties hereby waive all rights to a
trial by jury. In any action, arbitration or proceeding, including appeal, arising out of or relating to any of the Transaction
Documents or otherwise involving the parties, the prevailing party will be awarded its reasonable attorneys’ fees and other
costs and expenses reasonably incurred in connection with the investigation, preparation,
prosecution or defense of such action or proceeding.

 

F.
Arbitration. Any dispute, controversy, claim or action of any kind arising out of, relating
to, or in connection with this Note, or in any way involving Company and Investor or their respective Affiliates, including any
issues of arbitrability, will be resolved solely by final and binding arbitration in English before a retired judge at JAMS, or
its successor, in the Territory of the Virgin Islands, pursuant to the most expedited and Streamlined Arbitration Rules and Procedures
available. Any interim or final award may be entered and enforced by any court of competent jurisdiction. The final award will
include the prevailing party’s reasonable arbitration, expert witness and attorney fees, costs and expenses. Notwithstanding
the foregoing, Investor may in its sole discretion bring an action in Nevada or Utah in aid of arbitration or for temporary, preliminary
or provisional relief pending completion of arbitration.

 

    	 	14	 

    	 	 	 

    

 

G.
Remedies.

 

1.
In addition to being entitled to exercise all rights provided herein or granted by law, including
recovery of damages, each of Investor and Company will be entitled to specific performance under this Note, and equitable and
injunctive relief to prevent any actual or threatened breach under this Note, to the full extent permitted under applicable laws.

 

2.
Without limitation of the foregoing, Company acknowledges that the rights and benefits of Investor
pursuant to Section I.G.1. of this Note are unique and that no adequate remedy exists at law if Company breaches or fails timely
perform any of its obligations thereunder, that it would be difficult to determine the amount of damages resulting therefrom,
that it would cause irreparable injury to Investor, and that any potential harm to Company would be adequately and fully compensable
with monetary damages; accordingly, Investor will be entitled to a compulsory remedy of immediate specific performance, temporary,
interim, preliminary and final injunctive relief to enforce the provisions thereof, including without limitation requiring Company
and its transfer agent, attorneys, officers and directors to immediately take all actions necessary to issue and deliver the number
of Conversion Shares stated by Investor, and prohibiting any Common Stock from being issued or transferred until after all Conversion
Shares have been received by Investor in electronic form and fully cleared for trading, which requirements will not be stayed
for any reason, without the necessity of posting any bond. Company hereby absolutely, unconditionally and irrevocably waives all
objections and rights to oppose any motion, application or request by Investor to issue any number of Conversion Shares, and all
rights to stay or appeal any resulting order, and any appeal filed by Company or on its behalf will be immediately and automatically
dismissed. Company further acknowledges that it has an adequate remedy at law with respect to Section I.G.1. of this Note in a
claim for money damages; accordingly, Company may not restrain or enjoin its transfer agent, Investor or any brokers from receiving
or reselling any Conversion Shares, and any action for temporary, preliminary or final injunctive relief filed by Company or on
its behalf will be immediately and automatically dismissed.

 

H.
Headings. The titles and headings in
this Note are for convenience only, do not constitute a part of this Note and will not be deemed to limit or affect any of the
provisions hereof

 

I.
Time of the Essence. Time is of the essence with respect to all provisions of this Note.

 

J.
Construction. The parties agree that each
of them and/or their respective counsel has reviewed and had an opportunity to revise this Note and, therefore, the normal rule
of construction to the effect that any ambiguities are to be resolved against the drafting party will not be employed in the interpretation
of this Note or any amendments hereto. The language used in this Note will be deemed
to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against
any party. All currency references in this Note are to U.S. dollars.

 

K.
Further Assurances. Each party will take all further actions and execute all further
documents as may be reasonably necessary to implement the provisions and carry out the intent of this Note fully and effectively.

 

L.
Entire Agreement. This Note, together with the Agreement, contains
the entire agreement and understanding of the parties, and supersedes all
prior and contemporaneous agreements, term sheets, letters, discussions, communications
and understandings, both oral and written, which the parties acknowledge have
been merged into this Note. No party, representative, advisor, attorney or agent has relied upon any collateral contract,
agreement, assurance, promise, understanding, statement or representation not expressly set forth herein. The parties hereby absolutely,
unconditionally and irrevocably waive all rights and remedies, at law and in equity, directly or indirectly arising out of or
relating to, or which may arise as a result of, any Person’s reliance on any such statement or assurance.

 

    	 	15	 

    	 	 	 

    

 

IN
WITNESS WHEREOF, the undersigned have executed this Note on May 20, 2019.

 

	INCEPTION
    MINING INC.	 
	 	 	 
	Signed:
    	/s/
    Trent D’Ambrosio	 
	 	Trent
    D’Ambrosio, CEO	 

 

    	 	16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00296-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00296-of-00352.parquet"}]]